New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
February 27, 2015
16:06 EDTAAPLOptions Update; February 27, 2015
Subscribe for More Information
12:50 EDTAAPLApple CEO says consumers will find many reasons to admire watch, Telegraph says
Apple CEO Tim Cook said that people will buy Apple's Apple Watch for one reason, and then discover that they like it for many reasons, according to The Telegraph. The watch will give users rewards if they hit exercise goals and could be used to replace car keys and security fobs used by many vehicles, the newspaper quoted Cook as saying. Reference Link
11:33 EDTNVSNovartis says phase II data highlights benefits of Alcon RTH258 in wet AMD
Novartis reports Alcon presented positive results from its second Phase II clinical study of RTH258 during the 38th Annual Macula Society Meeting. This study evaluated the efficacy and safety of the compound versus aflibercept in patients with neovascular age-related macular degeneration, or wet AMD. The Phase II study met its primary endpoint, demonstrating promising visual acuity gains that were non-inferior to aflibercept, with numerically greater reduction and rapid improvement in abnormal retinal fluid observed in RTH258-treated patients. Patients treated every three months with RTH258 also experienced a prolonged duration-of-action, potentially leading to a reduced treatment burden. A total of 90 patients diagnosed with wet AMD participated in the prospective, randomized, double-masked multicenter, two-arm study. The primary objective was to compare the efficacy of RTH258 6mg versus aflibercept 2mg with the primary endpoint being the mean change in best corrected visual acuity, from Baseline to Week 12. Secondary endpoints included the change assessment in BCVA and central subfield foveal thickness as measured by spectral domain optical coherence tomography. Both RTH258 and aflibercept were well tolerated and no new safety signal was reported during the study.
10:17 EDTBLKBlackRock invests $300M in Jawbone, Fortune reports
Subscribe for More Information
09:59 EDTAAPLApple slips below $130, levels to watch
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL MCD GOOG MNST BAC TSLA NFLX SINA AMZN WYNN
08:29 EDTJPMJPMorgan, Deutsche Bank pause plans for $2B Argentina bond sale, WSJ says
Deutsche Bank (DB) and JP Morgan (JPM) have suspended plans to sell $2B of Argentinian bonds after a U.S. district judge ordered an emergency hearing on the potential sale, reports the Wall Street Journal, citing people familiar with the matter. The sources said the banks believed they had found a way to sell the bonds without being blocked by a prior U.S. court ruling.Reference Link
07:50 EDTNVSNovartis holders approve dividend increase to CHF 2.60
Subscribe for More Information
07:25 EDTNVSNovartis lung cancer drug Zykadia recommended for EU approval
Subscribe for More Information
07:16 EDTNVSZykadia recommended by EMA for approval in advanced NSCLC
The European Medicines Agency has recommended granting a conditional marketing authorization for Zykadia. Zykadia is recommended for the treatment of adult patients with a type of lung cancer called anaplastic lymphoma kinase positive non-small cell lung cancer, or NSCLC, when the disease is advanced and has already been treated with crizotinib. The applicant for Zykadia is Novartis Europharm.
06:48 EDTAAPLApple hiring engineers to work on virtual reality products, 9to5Mac reports
Apple is hiring hardware engineers to work on virtual reality products, according to 9to5Mac, which cites job listings that have appeared this week. According to the ads, Apple is seeking to hire a Senior Display Systems Engineer for "display systems design and development related to VR environments" and a Senior Display Software Engineer to support graphics software engineering efforts for VR environments. Reference Link
06:39 EDTAAPLTexas company sues Apple over additional alleged patent violations, Reuters says
The Texas company that on Tuesday won a $533M patent infringement verdict against Apple (AAPL) is launching another patent lawsuit against the iPhone maker, according to Reuters. Filed Wednesday night, the new lawsuit addresses technology used by Apple devices that were launched after the previous case began, the news service stated. Reference Link
06:32 EDTAAPLCiti sees April 16 launch date for Apple Watch
Subscribe for More Information
05:26 EDTAAPLEricsson files lawsuits against Apple
Subscribe for More Information
February 26, 2015
16:52 EDTBKSOn The Fly: Closing Wrap
Stocks on Wall Street moved in a narrow range for most of the session while remaining near record levels. The Nasdaq was the strongest of the indices, as it continues its march towards 5,000. Crude oil prices fell by over 5% during the regular trading session, but recovered a bit in after-hours trading. The market is on pace to complete its fourth consecutive week of gains and close out the month of February with gains after suffering losses in January. ECONOMIC EVENTS: In the U.S., the Consumer Price Index fell 0.7% in January, with the core rate rising 0.2%, versus expectations for the headline CPI to be down 0.6% and the core rate to rise 0.1%. Initial jobless claims rose 31K to 313K in the week ended February 21, versus expectations for 290K first-time claims. Durable goods orders rose 2.8% in January, versus expectations for a 1.6% increase. The FHFA home price index rose 0.8% to 218.6 in December, versus expectations for an increase of 0.5%. COMPANY NEWS: The Federal Communications Commission voted 3 to 2 in favor of adopting new open Internet, or "net neutrality," rules. FCC Chairman Tom Wheeler has proposed that the FCC use its Title II authority to implement and enforce "bright-line" rules to ban paid prioritization and the blocking and throttling of lawful content and services. However, Wheeler said his proposal will "modernize" Title II, insuring there will be no rate regulation, no tariffs, and no last-mile unbundling. Major Internet Service Providers, including Verizon (VZ), AT&T (T), and Comcast (CMCSA), have opposed the rules, while Netflix (NFLX) has been a strong and vocal supporter of open Internet provisions... Shares of International Business Machines (IBM) slipped $1.94, or 1.19%, to $160.87 after Big Blue held its investor day meeting in NYC. At the meeting, IBM backed its fiscal year profit view but also said that the company now expects currency to impact revenue growth by over 6 points for the full year, which is greater than the impact previously provided based on January 16 spot rates. IBM also said it was shifting $4B into "strategic initiatives," including Big Data, the Cloud, mobile, social and security... Barnes & Noble (BKS) rose $1.67, or 6.89%, to $25.92 after announcing plans to split its Education business from its Retail and NOOK Digital businesses. The separation into two independent, publicly traded companies is anticipated to be completed by the end of August and is intended to be a tax-free distribution to shareholders, B&N noted. MAJOR MOVERS: Among the notable gainers was Emulex (ELX), which jumped $1.57, or 24.69%, to $7.93 after the company agreed to be acquired by Avago Technologies (AVGO) for $606M, or $8 per share in cash. Avago also rose $16.57, or 14.71%, to $129.25 after announcing the deal and reporting "beat and raise" quarterly results. Also higher was UIL Holdings (UIL), which gained $9.74, or 23.01%, to $52.07 after the company agreed to be acquired by Iberdrola USA to create a newly listed U.S. publicly-traded company. The proposed transaction implies total value per share to UIL shareholders of $52.75, including $10.50 per share paid in the form of cash, the companies said. Among the noteworthy losers was Clayton Williams (CWEI), which fell $11.41, or 17.77%, to $52.79 after the company suspended drilling operations in both of its core resource plays, citing low oil prices, and its shares were downgraded at Wunderlich. Also lower following their earnings reports were network solutions provider Inteliquent (IQNT), which dropped $3.05, or 17.33%, to $14.55, and electric weapons maker TASER (TASR), which slid $4.36, or 16.14%, to $22.68. INDEXES: The Dow fell 10.15, or -0.06%, to 18,214.42, the Nasdaq gained 20.75, or 0.42%, to 4,987.89, and the S&P 500 declined 3.12, or 0.15%, to 2,110.74.
16:00 EDTAAPLOptions Update; February 26, 2015
iPath S&P 500 VIX Short-Term Futures down 33c to 27.78. Option volume leaders: AAPL TSLA TWTR C ZNGA MCD RIG NFLX according to Track Data.
15:02 EDTJPMFed extends capital surcharge for SiFi banks comment period to April 3
The Federal Reserve extended until April 3 the comment period for its proposed rule to implement capital surcharges for the largest, most systemically important U.S. bank holding companies. The Fed extended the comment period to allow interested persons more time to analyze the issues and prepare their comments. Originally, comments were due by March 2. The proposed rule would establish a methodology to identify whether a firm is a global systemically important banking organization and would also establish the size of a firm's risk-based capital surcharge. The proposal is designed to further strengthen the capital positions of these institutions. Large U.S. banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
14:01 EDTJPMBarclays to double provision for forex rigging fines, Sky News says
Barclays (BCS), which previously excluded itself from a broader settlement between several banking peers and regulators over alleged manipulation of foreign exchange rates as it worked to secure a binding agreement with all relevant authorities, will more than double its existing provision for forex fines next week, which may indicate that a settlement deal could be announced soon, said Sky News. Barclay took a GBP500M charge during the course of last year in advance of expected forex issue costs, the report noted. Other banks that previously agreed to a settlement included Bank of America (BAC), Citibank (C), HSBC (HSBC), JPMorgan Chase (JPM), RBS (RBS) and UBS (UBS). The report indicates that U.S. regulators have stepped up talks with banks including Barclays and the others involved. Reference Link
12:05 EDTAAPLApple to host event on March 9, Business Insider reports
Subscribe for More Information
11:15 EDTAAPLStocks with call strike movement; AAPL CRM
Subscribe for More Information
10:50 EDTJPMNew York regulator considering cybersecurity, cash laundering controls, WSJ says
Subscribe for More Information
10:24 EDTAAPLApple falls, levels to watch
Subscribe for More Information
10:22 EDTAAPLTesla jumps 2% as Chinese language report fuels speculation
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:05 EDTNVSFDA grants Sandoz tentative approval of Fusilev generic
The FDA posted on its website that it granted Novartis's Sandoz tentative approval for levoleucovorin calcium, a generic of Spectrum's (SPPI) colon cancer drug Fusilev. Reference Link
09:02 EDTBKSBarnes & Noble to separate College business from Retail and NOOK businesses
Subscribe for More Information
09:01 EDTBKSBarnes & Noble to separate College business from Retail and NOOK businesses
Subscribe for More Information
07:58 EDTAAPLAvago price target raised to $145 from $120 at Brean Capital
Subscribe for More Information
06:02 EDTVIA, VIABViacom's Nickelodeon announces launch of Noggin mobile subscription service
Subscribe for More Information
February 25, 2015
16:00 EDTAAPLOptions Update; February 25, 2015
Subscribe for More Information
15:50 EDTAAPLApple pivots lower, levels to watch
Subscribe for More Information
14:10 EDTNVSPharmacyclics downgraded to Hold on lack of upside at Deutsche Bank
Subscribe for More Information
13:34 EDTJPMDeutsche Bank hires JPMorgan senior banker Jeff Urwin
Subscribe for More Information
13:14 EDTAAPLFirm says iPad's market share fell sharply, Business Insider reports
Subscribe for More Information
12:54 EDTNVSPharmacyclics exploring options including sale, Bloomberg reports
According to sources, Pharmacyclics (PCYC), which develops cancer treatments, is currently exploring options, Bloomberg reports. One option may include a sale of the company, and the sources say Johnson & Johnson (JNJ) and Novartis (NVS) have expressed interest in the company. Pharmacyclics could fetch $17B-$18B in a sale, the sources add. Reference Link
12:53 EDTNVSPharmacyclics weighing sale to U.S. drugmaker, Bloomberg reports
Subscribe for More Information
12:13 EDTNVSGlaxoSmithKline sees Novartis transaction closing next week
Subscribe for More Information
11:47 EDTVIAAnalysts clash on DreamWorks following Q4 miss
The shares of animated film and television show maker DreamWorks (DWA) are rising, despite the weaker than expected results reported by the company last night. Two analysts offered very different views on the company's outlook following its results. BACKGROUND: DreamWorks last night reported a fourth quarter per share loss of ($3.08), versus analysts' consensus outlook for a ($3.01) per share loss. The company's revenue also came in below expectations. Excluding $210M in pre-tax charges associated with DreamWorks' restructuring plan, its loss was (75c) per share, the company stated. BEARISH TAKE: In a note to investors today, FBR Capital analyst Barton Crockett wrote that DreamWorks' results were "ugly," as they included $155M of write-offs on films and TV shows. However, Crockett believes that the crucial factor for the company's outlook is whether it can consistently compete with the entertainment giants, including Disney (DIS), Viacom (VIA), and Time Warner (TWX). Crockett is not convinced that DreamWorks will be able to hold its own, and he believes that its 2015 results could come in below expectations. The analyst warned that the company may have difficulty meeting its 2015 consumer products revenue guidance. DreamWorks expects its consumer products revenue to double this year, but the movie-based toy space is "very competitive" in 2015, as toys based on multiple popular children's films are set to be released, Crockett stated. Moreover, after conducting checks online, Crockett reports that there does not seem to be a great deal of interest in DreamWorks' movie "Home," which is set to be released on March 27. He kept an Underperform rating on the shares and raised his price target on the stock to $14 from $12. BULLISH TAKE: DreamWorks' results were mixed, but the results are not very important, Piper Jaffray analyst James Marsh stated. The company's guidance for its TV and consumer products businesses were solid, the analyst believes. Moreover, the company "took specific and decisive action" to avert a liquidity crunch, Marsh wrote. Specifically, DreamWorks raised $185M of capital by selling its real estate in Glendale, California and then leasing it back, and increased the size of its current credit facility to $450M from $400M, Marsh reported. The moves should "largely" eliminate investors' worries about the company's liquidity position, Marsh stated. He kept a $26 price target and Overweight rating on the stock. WHAT'S NOTABLE: On DreamWorks' earnings conference call last night, the company's CEO Jeffrey Katzenberg stated that it did not obtain more than 10% of its revenue from Netflix (NFLX) last year. However, in an SEC filing earlier this morning, DreamWorks clarified that it had obtained 14.9% of its revenue from Netflix last year. PRICE ACTION: In late morning trading, DreamWorks rose 5.6% to $22.31.
10:01 EDTAAPLIDC reports Samsung retains 22% smartphone marketshare in India
Subscribe for More Information
09:48 EDTAAPLIDC reports 96.3% smartphone marketshare for iPhone, Android
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL HPQ PBR FSLR MRVL TSLA LVS ABX TWTR MGM
09:25 EDTAAPLCisco, Apple among U.S. names cut from China state buying list, Reuters says
Subscribe for More Information
09:01 EDTAAPLMorgan Stanley says Apple Pay available for Wealth Management clients
Subscribe for More Information
08:47 EDTJPMJPMorgan valuation discount overdone, says Goldman
Subscribe for More Information
08:33 EDTJPMJPMorgan core franchise outlook positive, says Bernstein
Subscribe for More Information
08:07 EDTNVSNovartis' Farydak myeloma drug approved by FDA, to be distributed by Diplomat
Novartis' (NVS) drug Farydak for the treatment of patients with multiple myeloma Diplomat Pharmacy has been approved by the FDA. The drug is now a treatment option for patients with multiple myeloma who have received at least two prior regimens, including bortezomib and an immunomodulatory agent. Farydak will be distributed by Diplomat Pharmacy (DPLO).
07:27 EDTAAPLApple reportedly creating streaming music service, may relaunch iTunes, BI says
Subscribe for More Information
07:13 EDTAAPLApple price target raised to $150 from $130 at Stifel
Stifel increased its price target on Apple as the firm thinks the company "has more than enough capacity" to increase its dividend to $2.30-$2.40 per share. The firm indicates that it believes that Apple can reduce its tax rate. Stifel keeps a Buy rating on the stock.
06:23 EDTJPMJPMorgan in talks with DOJ over auto loan pricing
Subscribe for More Information
06:22 EDTAAPLJury orders Apple to pay $533M for patent violations, Reuters reports
Subscribe for More Information
06:17 EDTVIASuddenlink claims 99.7% customer retention after dropping Viacom, NY Post says
Subscribe for More Information
06:13 EDTJPMJPMorgan to close 300 bank branches over two years, AP reports
Subscribe for More Information
06:01 EDTAAPLGlobal tablet shipments forecast at 221.4M units in 2015, DigiTimes says
Subscribe for More Information
February 24, 2015
16:19 EDTNVSAratana Therapeutics to pay Elanco up to $3M to regains rights to AT-004
Subscribe for More Information
16:06 EDTAAPLOptions Update; February 24, 2015
Subscribe for More Information
14:35 EDTAAPLMicron retreats amid pricing, Apple worries but analysts defend shares
Subscribe for More Information
12:15 EDTAAPLMicron sell-off 'totally unwarranted,' says Summit Research
Subscribe for More Information
11:29 EDTAAPLApple could thrive in auto sector, Morgan Stanley says
Subscribe for More Information
10:53 EDTJPMJPMorgan rises, levels to watch
Subscribe for More Information
10:43 EDTAAPLMicron drop on Apple speculation presents buying opportunity, says Stifel
Subscribe for More Information
10:14 EDTAAPLSamsung reportedly reaches deal with LG, Apple to supply DRAM, Korea Times says
Subscribe for More Information
09:35 EDTVIAB, AAPLActive equity options trading on open
Subscribe for More Information
09:25 EDTJPMJPMorgan sees pro forma net income growing to about $30B over 3 year horizon
Subscribe for More Information
09:11 EDTJPMJPMorgan CFO says will 'aggressively' manage G-SIB exposures
CFO Lake says may take at actions to reduce G-SIB buffer to 4% if required actions are accretive.
09:06 EDTJPMJPMorgan CFO says company seeks to raise dividends if approved
Subscribe for More Information
09:01 EDTJPMJPMorgan expects legal costs to ease, but remain above pre-crisis levels
08:55 EDTJPMJPMorgan expect net charge offs to remain low at $4B+ in 2015
Subscribe for More Information
08:39 EDTAAPLApple near-term capital return could be less than expected, says UBS
UBS said they believe Apple could take a near-term breather on capital returns due to potential U.S. tax reform, increased dependence on debt issuance for stock buyback funding, and the potential for its board to wait for more clarity on repatriation. UBS reiterated its Buy rating and $150 price target on Apple shares.
07:21 EDTVIA Viacom reportedly planning job cuts, Bloomberg says
Subscribe for More Information
07:21 EDTJPMSecurities Industry & Financial Markets Association to hold a conference
Subscribe for More Information
06:39 EDTAAPLVisa Europe announces 'tokenisation service'
Subscribe for More Information
06:29 EDTAAPLApple hiring chip, battery experts from Samsung, Korea Times reports
Subscribe for More Information
06:27 EDTAAPLApple said to buy music plug-in and effect makker Camel Audio, MacRumors says
Subscribe for More Information
06:15 EDTJPMBanks probed for possible rigging of precious metals markets, WSJ reports
Officials in the U.S. are investigating at least 10 major banks for potential rigging of precious-metals markets, sources tell The Wall Street Journal. The DOJ's antitrust unit are investigating the price-setting process for gold, silver, palladium and platinum in London, while the CFTC has begun a civil investigation, with both agencies making requests for information, including a subpoena to HSBC (HSBC) from the CFTC. According to a source, Credit Suisse (CS), JP Morgan (JPM), UBS (UBS), Societe Generale (SCGLY), Bank of Nova Scotia (BNS), Barclays (BCS), Goldman Sachs (GS) and Deutsche Bank (DB) are also under investigation. Reference Link
06:12 EDTJPMJPMorgan plans to charge fees for deposits from large clients, WSJ says
JPMorgan is planning to charge corporate clients, hedge funds, private-equity firms, and foreign banks for deposits due to regulatory rules that impose costs on holding money viewed as "prone to fleeing" during financial stress, reports the Wall Street Journal, citing an internal memo and people familiar with the plan. Clients will be asked to pay a fee or move funds to other products such as money-fund sweep accounts. Retail customers are unaffected. Reference Link
06:06 EDTAAPLApple's market cap hits nearly $775B, CNBC reports
Apple's (AAPL) market cap has reached nearly $775B after the stock closed at a record on Monday, up over 2.7% to $133, CNBC reports. Exxon Mobil (XOM) has a market cap of about $377B. Reference Link
05:59 EDTAAPLStocks with implied volatility movement; BBRY AAPL
Subscribe for More Information
February 23, 2015
16:00 EDTAAPLOptions Update; February 23, 2015
Subscribe for More Information
15:17 EDTAAPLAOL iTunes login pact with Apple ending soon, AppleInsider says
Subscribe for More Information
15:00 EDTNVSFDA approves Farydak for treatment of multiple myeloma
The FDA approved Farydak for the treatment of patients with multiple myeloma, a form of blood cancer that arises from plasma cells, a type of white blood cell, found in bone marrow. Farydak is the first HDAC inhibitor approved to treat multiple myeloma. It is intended for patients who have received at least two prior standard therapies, including bortezomib and an immunomodulatory agent. Farydak is to be used in combination with bortezomib, a type of chemotherapy, and dexamethasone, an anti-inflammatory medication. Farydak is marketed by Novartis.
13:40 EDTNVSAnalysts clash on Spectrum outlook after patent suit setback
Two research firms had divergent views on Spectrum Pharmaceuticals (SPPI) after a judge ruled that a drug which could compete with the company's Fusilev treatment does not infringe on the company's intellectual property. BACKGROUND: Late Friday, a federal judge ruled that Novartis' (NVS) levoleucovorin, a generic version of Spectrum's Fusilev, does not infringe on Spectrum's intellectual property. Fusilev is indicated after high-dose methotrexate therapy in osteosarcoma, a type of cancer that starts in the bones. It is also used to treat patients with advanced metastatic colorectal cancer. BEARISH TAKE: Roth Capital analyst Joseph Pantginis downgraded Spectrum to Neutral from Buy following the ruling, as he believes the risk to the company's revenue has risen. The company is meaningfully less likely to become profitable again, wrote Pantginis, noting that Fusilev accounted for about 50% of the company's product revenue. According to the analyst, Spectrum is becoming increasingly focused on developing its earlier stage drugs, and he expects those drugs to grow slowly. Pantginis slashed his price target on the shares to $7 from $15. BULLISH TAKE: In a note to investors earlier today, Reni Benjamin, an analyst at research firm H.C. Wainwright, wrote that the stock's plunge after the judge's ruling "creates a table-pounding buying opportunity," noting that Fusilev has been granted exclusivity as a colorectal treatment until 2018. Benjamin does not expect the company's revenue from Fusilev to decline at all until 2018, as a citizen's petition submitted by Spectrum to the FDA, along with an appeal the company is mounting to Friday's ruling, and the difficulty that Novartis will have launching its version of the drug while the appeal is ongoing, will help prevent Spectrum's revenue from dropping. Also likely to protect Spectrum's revenue are the strong relationships that the company has developed with hospitals and community doctors, the analyst stated. He kept a $15 price target and Buy rating on the shares. PRICE ACTION: In mid-afternoon trading, Spectrum tumbled $1.44, or 19.3% to $6.02.
12:28 EDTAAPLGoogle reaches deal with wireless carriers, acquires Softcard tech, Re/code says
Subscribe for More Information
12:21 EDTNVS, AAPLOn The Fly: Midday Wrap
Subscribe for More Information
12:12 EDTAAPLReport: Apple may be targeting next-gen experts from Samsung, Apple Insider says
Subscribe for More Information
11:17 EDTNVSFTC puts conditions on Novartis's proposed acquisition of GSK oncology drugs
According to the FTC, Global pharmaceutical company Novartis (NVS) has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in development, to Boulder, Colorado-based Array BioPharma (ARRY) to settle charges that Novartis’s $16B acquisition of GlaxoSmithKline’s (GSK) portfolio of cancer-treatment drugs would likely be anticompetitive...If the acquisition goes forward as proposed, Novartis would likely delay or terminate development of both its BRAF and MEK inhibitors, as well as the combination product. For that reason, Novartis’s acquisition of GSK’s portfolio of cancer-treatment drugs would likely cause significant competitive harm in the U.S. markets for both the BRAF and MEK inhibitors, ultimately raising prices for consumers and depriving them of potentially superior products. Under the terms of the proposed consent agreement, Novartis is required to provide transitional services to Array BioPharma to ensure that development of the BRAF and MEK inhibitors continues uninterrupted and that competition in BRAF and MEK inhibitor markets is not reduced. Reference Link
11:08 EDTJPMJPMorgan weekly volatility elevated into investor day
Subscribe for More Information
10:21 EDTGDGeneral Dynamics awarded $415M contract by US Army
Subscribe for More Information
10:11 EDTAAPLApple breakout continues, levels to watch
Subscribe for More Information
09:39 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:04 EDTAAPLApple volatility flat as shares near record
Subscribe for More Information
08:57 EDTJPMJPMorgan to host investor day
Subscribe for More Information
08:33 EDTVIAB'Fifty Shades' ticket sales retain top spot at box office, Reuters says
Subscribe for More Information
07:29 EDTAAPLJapan Display asking Apple to finance new smartphone screen plant, Reuters says
Subscribe for More Information
07:14 EDTNVSSpectrum says plans to appeal patent suit loss to Novartis unit
Spectrum Pharmaceuticals (SPPI) confirmed in a regulatory filing that on February 20, the U.S. District Court for the District of Nevada ordered that judgment be entered in favor of defendant Sandoz in the matter entitled Spectrum Pharmaceuticals, Inc. et al v. Sandoz Inc. "Spectrum Pharmaceuticals Inc. intends to appeal this decision and the ultimate outcome of this litigation remains uncertain," the company stated. Sandoz is the generic pharmaceuticals division of Novartis (NVS).
06:21 EDTAAPLFacebook's shuttle drivers approve new union contract, WSJ reports
Subscribe for More Information
06:04 EDTAAPLApple to publicly beta test iOS update, Re/code says
Apple plans to allow consumers to test the next update for its iOS mobile operating system, reports Re/code. The beta test will be available mid-March through the company's Apple Seed program. Reference Link
05:29 EDTAAPLApple to invest EUR 1.6B in new European data centers
Subscribe for More Information
05:27 EDTAAPLApple to invest EUR 1.6B in new European data centers
February 22, 2015
17:11 EDTAAPLApple could reach $160 in a year, Barron's says
Subscribe for More Information
15:11 EDTAAPLApple increases capabilities in industrial lithium-ion batteries, Reuters says
Subscribe for More Information
February 20, 2015
16:48 EDTAAPLDow, S&P 500 finish week at record highs after Greek deal reached
Subscribe for More Information
16:03 EDTAAPLOptions Update; February 20, 2015
Subscribe for More Information
11:02 EDTAAPLApple electric car could be 'iPhone of the Future,' says Cantor
Cantor Fitzgerald analyst Brian White says he believes an electric car from Apple has the potential to be the "iPhone of the Future." White, in a note to investors today, added that he doubts Apple's reach will stop there. He believes the personal robot category offers "great potential over the next decade and fits well with Apple's skill set." White thinks the reports of an electric car show innovation at the tech giant continues. He keeps a Buy rating Apple shares with a $160 price target. The stock is up 30c it morning trading to $128.71.
11:00 EDTAAPLApple electric car could be 'iPhone of the Future,' sys Cantor
Subscribe for More Information
09:38 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:08 EDTNVSAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
06:41 EDTAAPLApple pushing for 2020 production of its electric car, Bloomberg says
Apple (AAPL) is pushing to begin production of its electric vehicle as soon as 2020, reports Bloomberg, citing people with knowledge of the matter. Bloomberg notes that the move could put Apple into direct competition with Tesla (TSLA) and General Motors (GM), both of which are targeting a 2017 release for next-generation electric vehicles. Apple may still cancel the project if it becomes unhappy with progress, the sources said, though its vehicle team is already 200-people strong. Reference Link
06:20 EDTAAPLApple price target raised to $145 on increasingly bullish outlook at Goldman
Goldman raised Buy rated Apple's price target to $145 from $130 based on increased confidence in platform momentum, sustained iPhone growth, and the potential for the Apple Watch. The firm believes risk/reward is more balanced following the recent 20% upside move but sees further upside given the aforementioned factors and the near-term catalysts from the April watch launch, updates on capital allocation, and a likely March quarter beat.
06:03 EDTJPMAnn Inc. working with JPMorgan on potential sale, Bloomberg reports
Subscribe for More Information
February 19, 2015
17:58 EDTJPMAnn Inc. working with JPMorgan on potential sale, Bloomberg says
16:01 EDTAAPLOptions Update; February 19, 2015
iPath S&P 500 VIX Short-Term Futures down 70c to 30.11. Option volume leaders: AAPL TSLA TWTR AMAT PBR KO FB AXP NFLX according to Track Data.
12:58 EDTAAPLRecent Apple hires have backgrounds in automotive hardware, 9to5Mac says
Many of the automotive experts poached by Apple (AAPL) come from automotive hardware backgrounds, strongly hinting at development beyond automotive software, reports 9to5Mac, citing sources close to the company. The new hires have backgrounds in motor and gearbox design, safety components, transmissions, power trains, drive trains, electric vehicle batteries, hybrid vehicles, interior vehicle components, and other areas. Reference Link
11:51 EDTAAPLCiti, RBC lay out reasons to be bullish on Apple
Subscribe for More Information
09:35 EDTAAPLOption volume leaders
Option volume leaders: AAPL TSLA TWTR MCD WMT PBR SPWR WFM GILD FB SCTY according to Track Data.
08:50 EDTAAPLApple could return $150B-$200B to shareholders, says RBC Capital
RBC Capital believes that Apple could return $150B-$200B to its shareholders over the next three years. The firm expects the company to return 100% of its annual free cash flow to shareholders. It raised its price target on the name to $140 from $130 and keeps an Outperform rating on the stock.
08:21 EDTAAPLApple Pay faces resistance from China, MarketWatch says
Apple (AAPL) is attempting to launch Apple Pay in China, but a People's Bank of China official stated the company has not acknowledged regulators and "it's unclear whether the product meets the government’s requirements,” while talks with state-owned card payment operator UnionPay "have stalled" according to sources close to the companies, reports MarketWatch. Alibaba (BABA) currently operates the similar Alipay service and an Alibaba employee stated the two companies "have stayed in contact and are preparing for several projects," but because all payments go through UnionPay, Apple's entry into the market is ultimately controlled by the state-owned firm. The Chinese government has raised numerous concerns regarding Apple Pay, and is demanding the company open a mainland China data center to house customer information. Reference Link
08:15 EDTAAPLWarner Bros. exec says not in talks with Apple on streaming, Re/code reports
Subscribe for More Information
07:46 EDTGDAustralia opens bids for $8B armored vehicle defense contract, WSJ says
Subscribe for More Information
07:25 EDTVIA, VIABCable nets speed up shows to add more ads, WSJ says
Subscribe for More Information
07:12 EDTNVSWharton Health Care Club to hold a conference
Subscribe for More Information
06:47 EDTJPMReport shows subprime consumer loans at pre-2007 levels, WSJ says
Equifax (EFX) has released a report stating nearly 40%, or 50M, of auto loans, credit cards, and personal loans during the first 11 months of 2014 were made to subprime customers, the highest levels since the 2007 financial crisis, reports the Wall Street Journal. LendingTree (TREE) Chief Marketing Officer Gabriel Dalporto attributes the growth to nonbank lenders under less regulatory scrutiny than large banks. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
06:39 EDTAAPLA123 Systems sues Apple for poaching employees, WSJ reports
Subscribe for More Information
06:22 EDTAAPLCiti lists five reasons for why Apple shares are going higher
Subscribe for More Information
February 18, 2015
16:00 EDTAAPLOptions Update; February 18, 2015
Subscribe for More Information
09:37 EDTAAPLOption volume leaders on open
Option volume leaders: AAPL TSLA TWTR CELG APO NFLX AXP APA LNKD C GILD according to Track Data.
07:59 EDTAAPLBlackBerry files copyright lawsuit against Typo Products, AP says
Subscribe for More Information
07:21 EDTJPMJPMorgan, Citi top government report of riskiest banks, Reuters reports
Subscribe for More Information
07:15 EDTJPMPeterson Institute for International Economics to hold a discussion
Subscribe for More Information
07:12 EDTBLKCFA Society of Minnesota to hold a discussion
Subscribe for More Information
06:57 EDTJPMJPMorgan may shrink interest-rate trading, other units, Bloomberg says
Subscribe for More Information
06:52 EDTAAPLApple could bringing Touch ID to Mac, 9to5Mac says
Subscribe for More Information
06:45 EDTAAPLApple Watch launching without health monitoring functions, WSJ says
Subscribe for More Information
06:20 EDTAAPLApple awarded patent for wireless head-mounted display, Financial Times reports
Subscribe for More Information
February 17, 2015
17:02 EDTAAPLSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
16:22 EDTAAPLOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTAAPLOptions Update; February 17, 2015
Subscribe for More Information
13:18 EDTAAPLOmega Advisors gives quarterly update on stakes
Subscribe for More Information
12:56 EDTVIADecline of TV viewing accelerated, NY Post reports
Subscribe for More Information
12:50 EDTAAPLOn The Fly: Midday Wrap
Subscribe for More Information
12:49 EDTGDSpirit AeroSystems likely to collect some funds from Gulfstream,says Wells Fargo
After Spirit AeroSystems (SPR) disclosed in a February 13 regulatory filing that it had settled its dispute with General Dynamics' (GD) Gulfstream unit with respect to amounts due on G650 deliveries from 2010 through Q3 2013, Wells Fargo expects Spirit to collect some of the $135M that it held n retainage in accounts receivable for Gulfstream underpayments as of the end of last year. The firm says it cannot estimate the amount that Spirit will collect. It keeps an Outperform rating on Spirit.
10:46 EDTJPMJPMorgan reports January net credit losses 2.53% vs. 2.56% last month
Subscribe for More Information
10:31 EDTAAPLApple rises as analysts applaud reported auto ambitions
Subscribe for More Information
10:29 EDTRDSAHigh option volume stocks
High option volume stocks: RDSA JACK WUBA MT JAKK VDSI ECL ENR AVG NWBO
10:01 EDTGDGeneral Dynamics awarded $50M for Abrams tank production
Subscribe for More Information
09:40 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:45 EDTVIAB, VIAViacom sell-off largely overdone, says Jefferies
Subscribe for More Information
07:32 EDTAAPLApple asking suppliers to make 5M-6M Apple Watches in Q1, WSJ says
Subscribe for More Information
07:28 EDTAAPLApple design chief working on store redesign ahead of Watch, New Yorker says
Subscribe for More Information
07:22 EDTAAPLMitsubishi UFJ to hold a tour
Subscribe for More Information
07:15 EDTAAPLApple foray into autos would be logical, says Barclays
Subscribe for More Information
07:15 EDTVIA, VIAB'Fifty Shades' opens to $94.4M, WSJ says
Comcast (CMCSA, CMCSK) subsidiary Universal's "Fifty Shades of Grey" earned roughly $94.4M in its opening weekend, reports the Wall Street Journal. The film earned an additional $172M overseas. Fox' (FOX, FOX.A) "Kingsman: The Secret Service" debuted in second place with $42M, and Viacom (VIA, VIA.B) subsidiary Paramount's "SpongeBob SquarePants: Sponge Out of Water" took $40M in its second week. Reference Link
07:08 EDTAAPLAuto market could be meaningful for Apple, says Cantor
Subscribe for More Information
February 15, 2015
16:44 EDTAAPLApple Watch could increase revenue by 10% next year, Barron's says
Subscribe for More Information
07:47 EDTAAPLHope of car positive for Apple shares, says Piper Jaffray
Piper Jaffray analyst Gene Munster said in a note to investors yesterday that the potential for a car gives investors something to look at as "the next big thing" for Apple. Munster believes the Wall Street Journal's report that Apple is building an electric car will help support the stock over the next six months. He believes it is unlikely that the company launches anything in the next five years, however. Munster reiterated an Overweight rating on Apple with a $160 price target. The stock closed Friday up 62c to $127.08.
07:46 EDTAAPLApple working on minivan-like electric vehicle, WSJ reports
Apple has "several hundred" employees working secretly toward creating an Apple-branded electric vehicle, Wall Street Journal reported yesterday, citing people familiar with the matter. The project is known internally as "Titan" and has a design that resembles a minivan, the Journal added. The Financial Times reported yesterday that the iPhone maker is recruiting experts in automotive technology and vehicle design. Reference Link
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use